Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
Individual Patient Compassionate Use of GX-I7
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Immune Related-adverse Events in Patients Receiving Immune Checkpoint Inhibitors
- Status
- UNKNOWN
- Phase
- N/A
Study Comparing Lymphoseek® vs. Albumin Nanocolloid in Head and Neck, Melanoma and Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE4
A Study of NIVO Plus IPI and Guadecitabine or NIVO Plus IPI in Melanoma and NSCLC Resistant to Anti-PD1/PDL1
- Status
- UNKNOWN
- Phase
- PHASE2
A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Surgery of Melanoma Metastases After Systemic Therapy
- Status
- WITHDRAWN
- Phase
- PHASE2
Intensive Medicines Monitoring Study of Toripalimab Monoclonal Injection (Tuoyi) .
- Status
- UNKNOWN
- Phase
- N/A
Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Study of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study to Evaluate OrienX010 in Combination With JS001 in the Treatment of Stage IV (M1c) Liver Metastasis From Melanoma
- Status
- UNKNOWN
- Phase
- PHASE1
ENB003 Plus Pembrolizumab Phase 1b/2a in Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Family Lifestyles, Actions, and Risk Education Intervention: Version 2
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HH2710 in Patient With Advanced Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Study to Evaluate OrienX010 in Combination With Toripalimab as Neoadjuvant Treatment in Advanced Melanoma
- Status
- UNKNOWN
- Phase
- PHASE1
A Retrospective Observational Study on the Long-term Effects of Ipilimumab-treated Pediatric Participants in the Dutch Melanoma Treatment Registry (DMTR)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
POINTING: Clinical Cohort Study of Patients With Melanoma and NSCLC Receiving Checkpoint Inhibitors
- Status
- RECRUITING
- Phase
- N/A
LITT and Pembrolizumab in Recurrent Brain Metastasis
- Status
- TERMINATED
- Phase
- PHASE1
Safety and Efficacy of Tag-7 Gene-modified Vaccine in Locally Advanced or Metastatic Malignant Melanoma or Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2